Parenteral Drug Association
Industry association; its Technical Reports are de-facto references for sterile and aseptic manufacturing.
What this page does not claim
SPEQ curates and cross-references these bodies. It is not affiliated with, accredited by, or endorsed by any of them, and a count of decoded standards is a measure of SPEQ’s coverage, not of a body’s importance.
WHAT PDA COVERS
The Parenteral Drug Association is a non-profit association focused on sterile and parenteral manufacturing science. Its Technical Reports are detailed, peer-developed references on topics where regulatory guidance states the requirement but not the method.
WHAT PDA PUBLISHES
- 01Technical Report No. 22 — Process Simulation for Aseptically Filled Products
- 02Technical Reports on sterilisation, container closure integrity, environmental monitoring, and visual inspection
- 03Points to Consider documents on emerging topics
- 04Survey and benchmarking reports on industry practice
HOW ITS REQUIREMENTS BITE
PDA has no regulatory role. Its Technical Reports gain authority through scientific rigour and broad adoption — TR 22 on aseptic process simulation, for example, is the reference practitioners use to design media fills that satisfy Annex 1 and the FDA aseptic guidance.
What practitioners get wrong
- Technical Reports supply the method where Annex 1 and FDA guidance state the expectation but leave the how open.
- TR 22 is the standard reference for media-fill design, run size, incubation, and acceptance criteria.
- They are consensus industry documents, not regulatory requirements — cite them as supporting rationale for a chosen approach, never as the requirement itself.
- Check the current revision; several key reports have been substantially updated following EU GMP Annex 1 (2022) and its contamination control strategy expectations.
- An inspector will accept "we followed TR 22" only if the site can also explain why that method suits its process — the report is a starting point for justification, not a substitute for it.
WHERE IT SITS INTERNATIONALLY
PDA Technical Reports are used alongside EU GMP Annex 1, the FDA aseptic processing guidance, and USP chapters as the practical toolkit for sterile manufacturing. Their role in the hierarchy is worth being precise about: regulation states what must be achieved, guidance states what the regulator expects to see, and a Technical Report is where the industry records how it has learned to actually do it.
PDA STANDARDS SPEQ DECODES · 2
DISCIPLINES IN PDA’S REMIT
PDA: frequently asked questions
Reference answers on Parenteral Drug Association’s mandate, what it publishes, and how its requirements acquire force.
What is the PDA?
The Parenteral Drug Association is a non-profit association focused on sterile and parenteral manufacturing science. Its Technical Reports are detailed, peer-developed references on topics where regulatory guidance states the requirement but not the method. PDA has no regulatory role.
What is PDA Technical Report 22?
Technical Report No. 22, Process Simulation for Aseptically Filled Products, is the standard reference practitioners use to design media fills — run size, incubation, and acceptance criteria — that satisfy EU GMP Annex 1 and the FDA aseptic guidance. Check the current revision.
Are PDA Technical Reports regulatory requirements?
No. They are consensus industry documents, not requirements — cite them as supporting rationale for a chosen approach, never as the requirement itself. An inspector will accept "we followed TR 22" only if the site can also explain why that method suits its process.